Chemours (CC) FY2017 results: revenue $6.2 billion, up 14.5% on the year
Chemours Co. (CC) reported revenue of $6.2 billion for fiscal 2017, the year ended 31 December 2017, up 14.5% on the year before. Net income was $746 million, up 10557.1%, and diluted earnings per share $3.91. The figures are the company's own, from the 10-K it filed with the SEC on 16 February 2018.
Revenue
$6.2 billion
+14.5% on the year
FY2013FY2017
Operating margin
15.9%
-1.7% a year earlier
FY2013FY2017
Net income
$746 million
+10,557.1% on the year
FY2013FY2017
Diluted EPS
$3.91
+9,675.0% on the year
FY2013FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
6,183
5,400
5,717
+14.5%
Cost of revenue
4,438
4,297
4,762
+3.3%
Gross profit
1,745
1,103
955
+58.2%
Gross margin
28.2%
20.4%
16.7%
Research and development
81.0
81.0
97.0
0.0%
Selling, general and administrative
626
946
632
-33.8%
Operating income
981
-94.0
4,630
Operating margin
15.9%
-1.7%
81.0%
Interest expense
214
219
132
-2.3%
Pre-tax income
912
-11.0
-188
Income tax
165
-18.0
-98.0
Effective tax rate
18.1%
n/a
n/a
Net income
746
7.0
-90.0
+10,557.1%
Net margin
12.1%
0.1%
-1.6%
Diluted EPS
$3.91
$0.04
-$0.50
+9,675.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
639
594
182
+7.6%
Capital expenditure
411
338
519
+21.6%
Free cash flow
228
256
-337
-10.9%
Free cash flow margin
3.7%
4.7%
-5.9%
Cash from investing
-370
357
-497
Cash from financing
352
-396
687
Depreciation and amortisation
273
284
267
-3.9%
Share-based compensation
29.0
19.0
17.0
+52.6%
Buybacks
106
0.0
n/a
Dividends paid
22.0
22.0
105
0.0%
Dividend per share
$0.29
$0.12
$0.58
+141.7%
Diluted shares, weighted
191m
183m
181m
+4.1%
Shares outstanding at period end
183m
183m
181m
+0.2%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
860
100
126
+760.0%
Non-controlling interest
5.0
4.0
4.0
+25.0%
Debt
4,112
3,591
4,014
+14.5%
Other liabilities
2,316
2,365
2,154
-2.1%
Total liabilities and equity
7,293
6,060
6,298
+20.3%
Fixed assets
3,008
2,784
3,177
+8.0%
Goodwill
153
153
166
0.0%
Intangible assets
13.0
17.0
10.0
-23.5%
Cash and equivalents
1,556
902
366
+72.5%
Receivables
847
742
757
+14.2%
Inventory
935
767
972
+21.9%
Other assets
781
695
850
+12.4%
Total assets
7,293
6,060
6,298
+20.3%
10-K for the year ended 31 December 2017, filed 16 February 2018: the filing.